These results revealed that blocking DNA sensing using inhibition of the KU/DNA-PKcs/ZAK/AKT pathway could reverse SLE diseases mainly through preventing metabolism reprogramming in activated CD4+ T cells. The gene discussed is AKT1; the disease is systemic lupus erythematosus.